PRESS RELEASE published on 02/28/2024 at 10:00, 2 years 1 month ago Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF published on 02/28/2024 at 10:00, 2 years 1 month ago Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE published on 02/14/2024 at 08:30, 2 years 1 month ago Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE published on 11/28/2023 at 09:00, 2 years 4 months ago EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE published on 11/02/2023 at 08:00, 2 years 5 months ago Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE published on 10/05/2023 at 16:55, 2 years 6 months ago EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE published on 10/05/2023 at 16:42, 2 years 6 months ago EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE published on 09/21/2023 at 09:00, 2 years 6 months ago Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE published on 09/12/2023 at 09:00, 2 years 7 months ago Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE published on 09/07/2023 at 09:00, 2 years 7 months ago Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
Published on 04/11/2026 at 02:00, 2 days 2 hours ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 2 days 2 hours ago Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 2 days 4 hours ago Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/12/2026 at 21:25, 7 hours 6 minutes ago CGTN AMERICA & CCTV UN: UN Chinese Language Day Celebration with "Chinese Language Shining Civilizations" Event
Published on 04/12/2026 at 20:15, 8 hours 16 minutes ago CGTN AMERICA & CCTV UN: Commemoration of 55th Anniversary of Ping-Pong Diplomacy Held in Beijing
Published on 04/11/2026 at 16:45, 1 day 11 hours ago CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 1 day 11 hours ago VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 1 day 12 hours ago VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/11/2026 at 16:29, 1 day 12 hours ago Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:26, 2 days 10 hours ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
Published on 04/10/2026 at 18:00, 2 days 10 hours ago Declaration of voting rights at the end of March 2026
Published on 04/10/2026 at 17:45, 2 days 10 hours ago Imerys-10-04-2026-implementation of the share buyback program